BeStock  
股票 › 生物科技 › REGN

再生元制药 REGN

美股市值排名 #226生物科技传染病
$904.35 +$1.45 (+0.16%)
休市 · Nov 7, 9:50 pm ET · 最新盘后价 $900.00 -0.48%
开盘$887.22
昨收$902.90
当日区间$887.04 – $911.64
成交量1.12M
市值$93.55B
市盈率(TTM)20.0
股息率0.41%

基本面

最新报告季度:Q3, ended Sep 2026

营收$5.12B+36.3% YoY
营业利润$2.07B+86.5% YoY
净利润$1.95B+33.5% YoY
摊薄每股收益$18.45+35.5% YoY
自由现金流$1.43B+3.9% YoY
经营现金流$1.78B

营收,近8个季度

$3.8BDec '24$3.0BMar '25$3.7BJun '25$3.8BSep '25$3.9BDec '25$3.6BMar '26$4.3BJun '26$5.1BSep '26

净利润,近8个季度

$917.7MDec '24$808.7MMar '25$1.4BJun '25$1.5BSep '25$844.6MDec '25$727.2MMar '26$1.3BJun '26$1.9BSep '26

各季度摊薄每股收益

8.06Dec '247.27Mar '2512.81Jun '2513.62Sep '257.86Dec '256.75Mar '2612.23Jun '2618.45Sep '26

各季度自由现金流

$995.8MDec '24$773.6MMar '25$737.6MJun '25$1.4BSep '25$880.0MDec '25$799.4MMar '26$521.8MJun '26$1.4BSep '26

年度营收

$8.5BFY20$16.1BFY21$12.2BFY22$13.1BFY23$14.2BFY24$14.3BFY25

盈利能力与资产负债表

毛利率85.8%
营业利润率30.4%
净利率28.5%
净资产收益率14.9%
资产收益率11.4%
投入资本回报率12.0%
流动比率3.35
负债/资产比率24.6%
现金及投资$9.30B
总负债$1.99B
净现金(净负债)$7.31B
自由现金流/营收21.5%

营收构成

2026/Q2 季度

按业务线

  • Collaboration revenue$2.46B 57.2%
  • EYLEA HD$596.30M 13.9%
  • EYLEA$412.20M 9.6%
  • Libtayo$342.60M 8.0%
  • Other revenue$193.30M 4.5%
  • Libtayo$146.80M 3.4%
  • Praluent$74.70M 1.7%
  • Evkeeza$53.30M 1.2%
  • Lynozyfic$16.50M 0.4%

利润表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
报告营业总收入 $5.12B $4.29B $3.61B $14.34B $3.88B
营业总收入 $5.12B $4.29B $3.61B $14.34B $3.88B
营业成本 $573.60M $576.50M $669.40M $2.10B $584.60M
毛利润 $4.54B $3.71B $2.94B $12.24B $3.30B
营业费用 $2.47B $2.29B $2.19B $8.54B $2.40B
销售及管理费用 $677.80M $662.10M $647.70M $2.70B $775.00M
研发费用 $1.79B $1.63B $1.54B $5.85B $1.63B
营业利润 $2.07B $1.42B $744.80M $3.70B $898.60M
非经营性利息净收入(支出) $171.20M $172.30M $170.60M $673.00M $181.10M
非经营性利息收入 $181.80M $183.30M $183.50M $716.80M $193.30M
非经营性利息支出 $10.60M $11.00M $12.90M $43.80M $12.20M
其他收入(支出) $43.20M -$65.00M -$84.20M $855.70M -$36.00M
证券出售收益 $60.30M $61.90M $25.00M $946.10M -$21.50M
特殊收益(费用) -$21.50M -$127.00M -$101.90M -$124.10M -$18.70M
-减:其他特殊支出 $21.50M $127.00M $101.90M $124.10M $18.70M
其他非经营性收入(支出) $4.40M $100,000.00 -$7.30M $33.70M $4.20M
税前利润 $2.28B $1.53B $831.20M $5.23B $1.04B
税费 $335.40M $230.90M $104.00M $725.80M $199.10M
净利润 $1.95B $1.30B $727.20M $4.50B $844.60M
持续经营利润 $1.95B $1.30B $727.20M $4.50B $844.60M
归属母公司净利润 $1.95B $1.30B $727.20M $4.50B $844.60M
归属普通股股东净利润 $1.95B $1.30B $727.20M $4.50B $844.60M
基本每股收益 $19.16 $12.62 $6.99 $43.07 $8.21
摊薄每股收益 $18.45 $12.23 $6.75 $41.48 $7.86
每股股息 $0.94 $0.94 $0.94 $3.52 $0.88
其他营业费用 – – – -$10.00M $0.00

资产负债表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
总资产 $44.41B $41.73B $40.87B $40.56B $40.56B
流动资产合计 $20.80B $18.45B $18.21B $18.02B $18.02B
现金及现金等价物与短期投资 $9.30B $7.99B $8.75B $8.61B $8.61B
-现金及现金等价物 $3.66B $2.46B $2.96B $3.12B $3.12B
-短期投资 $5.64B $5.54B $5.79B $5.49B $5.49B
应收款 $7.58B $6.57B $5.73B $5.74B $5.74B
-应收账款 $7.58B $6.57B $5.73B $5.74B $5.74B
存货 $1.99B $3.08B $3.10B $3.20B $3.20B
一年内递延资产 $900.50M – – – –
其他流动资产 $1.02B $801.70M $620.90M $474.80M $474.80M
非流动资产合计 $23.61B $23.28B $22.66B $22.54B $22.54B
固定资产净值 $5.73B $5.46B $5.27B $5.12B $5.12B
投资及预付款 $9.56B $9.83B $9.79B $10.26B $10.26B
-可供出售证券 $9.56B $9.83B $9.79B $10.26B $10.26B
商誉及其他无形资产 $1.32B $1.31B $1.29B $1.26B $1.26B
一年以上递延资产 $4.54B $4.38B $4.19B $4.08B $4.08B
其他非流动资产 $2.47B $2.31B $2.13B $1.82B $1.82B
负债合计 $10.91B $10.02B $9.45B $9.30B $9.30B
流动负债合计 $6.20B $5.53B $5.11B $4.37B $4.37B
应付款 $1.14B $1.16B $1.03B $1.29B $1.29B
-应付账款 $1.14B $1.16B $1.03B $939.00M $939.00M
一年内应计费用 $3.59B $2.97B $2.72B $2.53B $2.53B
短期债务及融资租赁负债 $720.00M $720.00M $720.00M – –
-一年内到期融资租赁负债 $720.00M $720.00M $720.00M – –
一年内递延负债 $749.80M $684.80M $636.20M $553.00M $553.00M
非流动负债合计 $4.70B $4.49B $4.34B $4.93B $4.93B
长期债务及融资租赁负债 $1.99B $1.99B $1.99B $2.71B $2.71B
-长期债务 $1.99B $1.99B $1.99B $1.99B $1.99B
-长期融资租赁负债 $0.00 $0.00 $0.00 $720.00M $720.00M
一年以上递延负债 $220.20M $220.40M $225.10M $208.70M $208.70M
其他非流动负债 $2.50B $2.28B $2.13B $2.02B $2.02B
股东权益合计 $33.50B $31.71B $31.42B $31.26B $31.26B
股东权益 $33.50B $31.71B $31.42B $31.26B $31.26B
股本 $100,000.00 $100,000.00 $100,000.00 $100,000.00 $100,000.00
-普通股 $100,000.00 $100,000.00 $100,000.00 $100,000.00 $100,000.00
-优先股 $0.00 $0.00 $0.00 $0.00 $0.00
资本公积 $15.17B $14.70B $14.40B $14.00B $14.00B
留存收益 $39.47B $37.62B $36.42B $35.80B $35.80B
减:库存股 $20.95B $20.57B $19.41B $18.61B $18.61B
不影响留存收益的损益 -$197.50M -$35.80M $11.90M $77.50M $77.50M
-固定资产原值 – – – $7.73B $7.73B
-累计折旧 – – – -$2.61B -$2.61B
-其他无形资产 – – – $1.26B $1.26B
-应付税款合计 – – – $351.30M $351.30M

现金流量表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
经营活动现金流 $1.78B $813.00M $1.08B $4.98B $1.17B
持续经营经营活动现金流净额 $1.78B $813.00M $1.08B $4.98B $1.17B
持续经营净利润 $1.95B $1.30B $727.20M $4.50B $844.60M
持续经营损益 -$60.30M -$61.90M -$25.00M -$946.10M $21.50M
折旧、折耗与摊销 $121.00M $123.70M $123.20M $543.70M $145.00M
递延税款 -$182.30M -$194.40M -$96.00M -$785.40M -$232.50M
其他非现金项目 $91.10M $54.90M $55.60M $135.50M $136.90M
营运资金变动 -$390.60M -$649.20M $36.50M $532.60M $5.90M
-应收款变动 -$1.01B -$838.50M $1.20M $498.10M -$51.20M
-存货变动 $112.30M -$28.20M $26.60M -$275.30M $2.10M
-预付资产变动 -$339.00M -$319.10M -$198.60M -$375.30M $82.80M
-应付账款及应计费用变动 $784.50M $492.70M $107.70M $736.80M -$24.70M
-其他营运资金变动 $64.80M $43.90M $99.60M -$51.70M -$3.10M
投资活动现金流净额 -$288.10M -$92.70M -$428.90M -$629.10M $220.30M
持续经营投资活动现金流净额 -$288.10M -$92.70M -$428.90M -$629.10M $220.30M
资本支出 -$300.20M -$240.20M -$230.60M -$898.40M -$248.70M
无形资产购置及出售净额 -$56.30M -$51.00M -$48.90M -$315.30M -$42.00M
投资购置及出售净额 $68.40M $198.50M -$149.40M $587.90M $511.30M
筹资活动现金流 -$290.20M -$1.22B -$802.20M -$3.72B -$780.10M
持续经营筹资活动现金流净额 -$290.20M -$1.22B -$802.20M -$3.72B -$780.10M
普通股发行净额 -$194.50M -$1.13B -$704.40M -$3.33B -$687.40M
已付现金股利 -$95.70M -$96.80M -$97.80M -$370.30M -$92.70M
期末现金余额 $3.67B $2.47B $2.97B $3.12B $3.12B
现金净变动 $1.21B -$504.30M -$152.20M $634.40M $610.90M
期初现金余额 $2.47B $2.97B $3.12B $2.49B $2.51B
汇率变动影响 $500,000.00 -$300,000.00 -$900,000.00 $300,000.00 -$300,000.00
自由现金流 $1.43B $521.80M $799.40M $3.77B $880.00M
固定资产购置及出售净额 – – – $0.00 $0.00
业务购买及出售净额 – – – -$3.30M -$300,000.00
其他筹资费用净额 – – – -$10.30M $0.00

讨论区

暂无评论——快来第一个聊聊 REGN。

登录后参与讨论。

Scroll to Top